Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)

American Journal of Hematology
Afaq AhmadGeraldine P Schechter

Abstract

Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagulant ultralarge multimers of von Willebrand factor (VWF) in the circulation due to autoantibody inhibition of VWF cleaving protease (ADAMTS-13), the enzyme that normally cleaves the ultralarge multimers. Rituximab, a chimeric monoclonal antibody against CD20, has been recognized as a useful therapy for antibody-mediated autoimmune disease. We therefore treated four patients with recurrent TTP with 2 or 4 weekly doses of rituximab in addition to corticosteroids, vincristine, plasma, or continuing plasma exchange. Three patients responded with prompt improvement in microangiopathic hemolytic anemia and thrombocytopenia, which allowed plasma exchange to be discontinued or avoided and prednisone to be rapidly discontinued. Two of the 3 responders have remained in unmaintained complete remission for 13+ months. The third patient relapsed at 13 months; a second course of rituximab and prednisone resulted in an unmaintained remission for 6+ months. All f...Continue Reading

Associated Clinical Trials

References

Nov 26, 1998·The New England Journal of Medicine·H M Tsai, E C Lian
Aug 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Koichi KokameYoshihiro Fujimura
Aug 23, 2002·The New England Journal of Medicine·Joel L Moake
Sep 28, 2002·American Journal of Hematology·Jens ChemnitzDietmar Söhngen
Oct 9, 2002·Blood Cells, Molecules & Diseases·Lorence A GuttermanHan-Mou Tsai
Oct 18, 2002·Blood·Adrian WiestnerGeraldine P Schechter
Jan 17, 2003·Annals of Internal Medicine·Xinglong ZhengMorey A Blinder
Feb 28, 2003·European Journal of Haematology·Han-Mou Tsai, Keith Shulman

❮ Previous
Next ❯

Citations

May 19, 2009·Journal of Materials Science. Materials in Medicine·Stephen W RothwellKathleen A Szabo
Nov 1, 2012·International Urology and Nephrology·Cristina Vega-CabreraRafael Selgas
Feb 28, 2007·Hematology·Massimo Franchini
Jan 1, 2010·Mediterranean Journal of Hematology and Infectious Diseases·Evi Stavrou, Hillard M Lazarus
Feb 28, 2013·Hämostaseologie·M SchallerJ A Kremer Hovinga
Feb 11, 2005·Intensive Care Medicine·Menno van der StraatenJacques Devriendt
Jan 1, 2005·Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis·Han-Mou Tsai
Apr 3, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·F BaudinP-L Blanc
Jan 31, 2009·Kidney International. Supplement·Stephen R FoleyUNKNOWN Members of the Canada Apheresis Group (CAG)
May 17, 2011·European Journal of Internal Medicine·Wilma Barcellini, Alberto Zanella
Dec 3, 2008·European Journal of Internal Medicine·Daan DierickxAndré Delannoy
Nov 21, 2007·La Revue de médecine interne·N SchleinitzJ R Harlé
Jan 24, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Fevzi AltuntasAli Unal
Aug 24, 2005·British Journal of Haematology·M C Kappers-KlunneA Brand
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·B LämmleL Alberio
Aug 21, 2008·Journal of Clinical Apheresis·Sushama JastiBernard Poiesz
Aug 11, 2006·Clinical and Laboratory Haematology·L BenetatosK L Bourantas
Mar 6, 2008·British Journal of Haematology·Bernadette Garvey
Apr 11, 2012·Transfusion·Vinai C BhagirathDonald M Arnold
Feb 18, 2011·American Journal of Hematology·Daan DierickxDrew Provan
Jul 17, 2013·Journal of Clinical Apheresis·Jatinder GoyalMarisa B Marques
Jan 7, 2014·British Journal of Haematology·Marie Scully, Tim Goodship
May 23, 2009·Internal Medicine Journal·S J ButterlyJ Sturtevant
Aug 22, 2015·European Journal of Internal Medicine·Antoine FroissartUNKNOWN French Reference Center for Thrombotic Microangiopathies
Feb 21, 2007·Expert Opinion on Pharmacotherapy·Spero R Cataland, Haifeng M Wu
Mar 19, 2015·Blood·Farzana A Sayani, Charles S Abrams
Mar 3, 2010·Thrombosis Research·Anna Maria LombardiFabrizio Fabris
Sep 13, 2018·Transfusion·William E PlautzMatthew D Neal
Aug 12, 2005·Current Opinion in Hematology·Spero R Cataland, Haifeng M Wu
Sep 3, 2005·American Journal of Hematology·Sarah M Scott, Zbigniew M Szczepiorkowski
Mar 17, 2007·Critical Reviews in Clinical Laboratory Sciences·Massimo Franchini, Giuseppe Lippi
Sep 23, 2014·American Journal of Clinical Oncology·Mary J NinanJames S Goodwin
Feb 8, 2007·Journal of Clinical Apheresis·Wilmar Patino, Ravindra Sarode
Feb 19, 2021·Clinical Case Reports·Mohamad Y KhatibAbdulqadir J Nashwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.